Publications
594
Citation | Title | ||
---|---|---|---|
Wang et al., 2021, | Citrus Huanglongbing is an immune-mediated disease that can be treated by mitigating reactive oxygen species triggered cell death of the phloem tissues caused by Candidatus Liberibacter asiaticus | ||
De Francesco et al., 2021, | Transcriptome profiling of Candidatus Liberibacter asiaticus in citrus and psyllids | ||
Merli et al., 2021, Frontiers in Microbiology | ‘Candidatus Liberibacter asiaticus’ Multimeric LotP Mediates Citrus sinensis Defense Response Activation | ||
CABI, 2021, Distribution Maps of Plant Diseases | Candidatus Liberibacter asiaticus. [Distribution map] | ||
Anonymous, 2021, EPPO Bulletin | PM 7/121 (2) ‘ Candidatus Liberibacter africanus’, ‘ Candidatus Liberibacter americanus’ and ‘ Candidatus Liberibacter asiaticus’ | ||
Darolt et al., 2021, Frontiers in Microbiology | The Genome of “Candidatus Liberibacter asiaticus” Is Highly Transcribed When Infecting the Gut of Diaphorina citri | ||
Huang et al., 2021, Frontiers in Microbiology | Bacteriomic Analyses of Asian Citrus Psyllid and Citrus Samples Infected With “Candidatus Liberibacter asiaticus” in Southern California and Huanglongbing Management Implications | ||
Li et al., 2021, Phytopathology® | Residue Dynamics of Streptomycin in Citrus Delivered by Foliar Spray and Trunk Injection and Effect on ‘Candidatus Liberibacter asiaticus’ Titer | ||
N.C. Vasconcelos et al., 2021, Phytopathology® | The Total Population Size of ‘Candidatus Liberibacter asiaticus’ Inside the Phloem of Citrus Trees and the Corresponding Metabolic Burden Related to Huanglongbing Disease Development | ||
Zhang et al., 2021, Chemical Biology & Drug Design | Discovery of novel SecA inhibitors against “ Candidatus Liberibacter asiaticus” through virtual screening and biological evaluation |